ArticleEJNMMI radiopharmacy and chemistry2025

Design and characterization of a novel prostate-specific membrane antigen-targeted radioligand modified with a fatty acid albumin binder for optimized circulation half-life.

Shaomei Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.